Skip to main content
PMC home page
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1986 Apr;62(2):107–110. doi: 10.1136/sti.62.2.107

Immunotherapeutic effect of the lactobacillus vaccine, Solco Trichovac, in trichomoniasis is not mediated by antibodies cross reacting with Trichomonas vaginalis.

A Gombosová, P Demes, M Valent
PMCID: PMC1011910  PMID: 3522408

Abstract

According to the producers of the lactobacillus vaccine, Solco Trichovac, its therapeutic effect in trichomoniasis is achieved by antibodies that are induced by the vaccination and cross react with Trichomonas vaginalis. Common antigens of Lactobacillus acidophilus from Solco Trichovac vaccine and T vaginalis were therefore sought by three different seroreactions. Immune serum against Lacidophilus obtained by vaccinating two healthy human volunteers and two rabbits with the original Solco Trichovac vaccine, as well as hyperimmune rabbit antiserum to T vaginalis, were tested with each of the two micro-organisms. No evidence of antigenic similarity between L acidophilus and T vaginalis was obtained with either serum in any of the three serological tests. A non-specific immunostimulatory effect therefore seems to be a more probable explanation of the mode of action of Solco Trichovac vaccine.

Full text

PDF
109

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DIAMOND L. S. The establishment of various trichomonads of animals and man in axenic cultures. J Parasitol. 1957 Aug;43(4):488–490. [PubMed] [Google Scholar]
  2. EFTHYMIOU C., HANSEN P. A. An antigenic analysis of Lactobacillus acidophilus. J Infect Dis. 1962 May-Jun;110:258–267. doi: 10.1093/infdis/110.3.258. [DOI] [PubMed] [Google Scholar]
  3. KOTT H., ADLER S. A serological study of Trichomonas sp. parasitic in man. Trans R Soc Trop Med Hyg. 1961 Jul;55:333–344. doi: 10.1016/0035-9203(61)90102-x. [DOI] [PubMed] [Google Scholar]
  4. Korik L. M., Liubimova L. K., Tovstoles K. F. Blizhaishie i otdalennye rezul'taty lecheniia bol'nykh trikhomonozom muzhchin trikhomonadnoi vaktsinoi. Vestn Dermatol Venerol. 1968 Mar;42(3):80–84. [PubMed] [Google Scholar]
  5. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  6. Milovanović R., Grcić R., Stojković L. Serological study with SolcoTrichovac, a vaccine against Trichomonas vaginalis infection in women. Gynakol Rundsch. 1983;23 (Suppl 2):39–45. doi: 10.1159/000269592. [DOI] [PubMed] [Google Scholar]
  7. Pavic R., Stojković L. Vaccination with SolcoTrichovac. Immunological aspects of a new approach for therapy and prophylaxis of trichomoniasis in women. Gynakol Rundsch. 1983;23 (Suppl 2):27–38. [PubMed] [Google Scholar]
  8. Quang L. B., Demes P., Valent M. Stúdium protilátkovej odpovede králikov imunizovaných Trichomonas vaginalis pomocou niekol'kých séroreakcií. Bratisl Lek Listy. 1984 Jul;82(1):825–833. [PubMed] [Google Scholar]
  9. REISENHOFER U. [On the susceptibility of Trichomonas vaginalis to different sera]. Arch Hyg Bakteriol. 1963 Feb;146:628–635. [PubMed] [Google Scholar]
  10. SAMUELS R., CHUN-HOON H. SEROLOGICAL INVESTIGATIONS OF TRICHOMONADS. I. COMPARISONS OF "NATURAL" AND IMMUNE ANTIBODIES. J Protozool. 1964 Feb;11:36–46. doi: 10.1111/j.1550-7408.1964.tb01718.x. [DOI] [PubMed] [Google Scholar]
  11. Shimohashi H., Mutai M. Specific antigens of Lactobacillus acidophilus. J Gen Microbiol. 1977 Dec;103(2):337–344. doi: 10.1099/00221287-103-2-337. [DOI] [PubMed] [Google Scholar]
  12. Stojković L. New evidence elucidating the mechanism of action of Gynatren/SolcoTrichovac. Gynakol Rundsch. 1984;24 (Suppl 3):29–37. doi: 10.1159/000269923. [DOI] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES